News | October 20, 2010

FDA Approves Safeguard for Prostate Cancer Radiotherapy

October 20, 2010 – The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a system designed to automate the response to organ motion during prostate cancer radiotherapy. The Calypso System, by Calypso Medical Technologies, could help decrease the side effects associated with prostate radiotherapy, such as bowel and bladder incontinence and sexual dysfunction.

The system, and its GPS for the Body technology, utilizes miniature implanted Beacon transponders to provide precise, continuous information on the location of the tumor during external beam radiation therapy. The real-time position information provided by the Calypso System allows physicians to deliver maximum radiation directly to the tumor while sparing the surrounding healthy tissues and organs from exposure.

The new gating technology allows therapists to set motion thresholds which automatically signal radiation delivery to be stopped each time the targeted tissue moves outside the preset threshold. Previously, the therapist had to manually intervene and halt radiation delivery when healthy tissue was in danger of receiving unintended radiation. Dynamic Edge Gating Technology automates this function with an immediate signal to the linear accelerator so the radiation beam can be disabled or re-enabled in response to organ motion.

Side effects occur when the tumor moves outside of the radiation field in response to normal physiologic processes such as digestion, coughing and breathing, as well as small movements by the patient. As a result, healthy tissue receives the intended radiation, and at the same time, the tumor fails to receive the fully prescribed radiation dose.

"Calypso's Dynamic Edge Gating Technology is the next step in addressing organ motion for our patients," said Parag Parikh, M.D., assistant professor of radiation oncology at Washington University in St. Louis. "By automatically turning off the radiation beam if the target moves out of the planned location, this allows new ways to minimize the irradiation of healthy tissue, leading to better outcomes and quality of life for our patients."

In May 2010, Urology published a study that demonstrated that patients whose radiation therapy delivery was guided by the Calypso System experienced a significant decrease in the side effects associated with prostate radiation treatment.

For more information: www.calypsomedical.com

Related Content

RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Feature | Treatment Planning | July 03, 2018 | By Jeff Zagoudis
A new software developed and recently tested at the MD Anderson Cancer Center demonstrated the ability to largely aut
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
RayStation Users Win Inaugural Treatment Planning World Championships
News | Treatment Planning | April 27, 2018
In the first World Championships of Treatment Planning, arranged by radiation oncology analytics company ProKnow and...
Brainlab Introduces New Hi-Res Planning Algorithm for VersaHD
News | Treatment Planning | April 24, 2018
Brainlab announced the implementation of a software solution that can achieve better radiation dose conformity around...
Varian Launches Velocity 4.0 Cancer Imaging Software
Technology | Treatment Planning | April 16, 2018
April 16, 2018 — Varian announced a new version of its Velocity cancer imaging software that includes Rapidsphere, a
Overlay Init